Rxo (RXO) Change in Receivables (2021 - 2026)

Rxo (RXO) has 6 years of Change in Receivables data on file, last reported at -$8.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables rose 89.47% year-over-year to -$8.0 million; the trailing twelve-month figure through Mar 2026 stood at $73.0 million (up 21.67% YoY), and the FY2025 full-year result was $5.0 million, down 95.41% from the prior year.
• Change in Receivables for Q1 2026 stood at -$8.0 million, down from $125.0 million in the prior quarter.
• Across five years, Change in Receivables topped out at $210.0 million in Q1 2022 and bottomed at -$122.0 million in Q2 2023.
• The 5-year median for Change in Receivables is -$27.0 million (2024), against an average of -$8.5 million.
• The widest annual swing landed in 2024, when Change in Receivables jumped 329.55%; it then sank 692.86% in 2025.
• A 5-year view of Change in Receivables shows it stood at -$102.0 million in 2022, then surged by 56.86% to -$44.0 million in 2023, then surged by 329.55% to $101.0 million in 2024, then advanced by 23.76% to $125.0 million in 2025, then tumbled by 106.4% to -$8.0 million in 2026.
• The last three Change in Receivables figures came in at -$8.0 million (Q1 2026), $125.0 million (Q4 2025), and $39.0 million (Q3 2025), per Business Quant data.

Peer Comparison